{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:30:10Z","timestamp":1794605410659,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Res Methodol"],"DOI":"10.1186\/s12874-025-02716-w","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T14:01:24Z","timestamp":1764943284000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Trial Sequential Analysis for dichotomous outcomes \u2013 a practical guide for systematic review protocols"],"prefix":"10.1186","volume":"25","author":[{"given":"Sophie","family":"Juul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian Gunge","family":"Riberholt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus Harboe","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim Birch","family":"Milan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurlaug Hanna","family":"Hafli\u00f0ad\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeppe Houmann","family":"Svanholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth Buck","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Chin Han","family":"Lew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Aninakwah","family":"Asante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne Pereira","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buddheera W. M. B.","family":"Kumburegama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Yii","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie Perrine","family":"Schaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"1","key":"2716_CR1","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12874-024-02318-y","volume":"24","author":"CG Riberholt","year":"2024","unstructured":"Riberholt CG, Olsen MH, Milan JB, Hafli\u00f0ad\u00f3ttir SH, Svanholm JH, Pedersen EB, et al. Major mistakes or errors in the use of trial sequential analysis in systematic reviews or meta-analyses\u2013the METSA systematic review. BMC Med Res Methodol. 2024;24(1):196.","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"2716_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2288-14-120","volume":"14","author":"JC Jakobsen","year":"2014","unstructured":"Jakobsen JC, Wetterslev J, Winkel P, Lange T, Gluud C. Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Med Res Methodol. 2014;14(1):120.","journal-title":"BMC Med Res Methodol"},{"key":"2716_CR3","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions. 2nd Edition. Chichester (UK): John Wiley & Sons, 2019.","DOI":"10.1002\/9781119536604"},{"key":"2716_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejim.2016.03.020","volume":"32","author":"S Garattini","year":"2016","unstructured":"Garattini S, Jakobsen JC, Wetterslev J, Bertel\u00e9 V, Banzi R, Rath A, et al. Evidence-based clinical practice: overview of threats to the validity of evidence and how to minimise them. Eur J Intern Med. 2016;32:13\u201321.","journal-title":"Eur J Intern Med"},{"issue":"9480","key":"2716_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0140-6736(05)66846-8","volume":"366","author":"C Young","year":"2005","unstructured":"Young C, Horton R. Putting clinical trials into context. Lancet. 2005;366(9480):107\u20138.","journal-title":"Lancet"},{"issue":"3","key":"2716_CR6","doi-asserted-by":"publisher","first-page":"e59202","DOI":"10.1371\/journal.pone.0059202","volume":"8","author":"RM Turner","year":"2013","unstructured":"Turner RM, Bird SM, Higgins JP. The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLoS ONE. 2013;8(3):e59202. https:\/\/doi.org\/10.1371\/journal.pone.0059202.","journal-title":"PLoS ONE"},{"key":"2716_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12874-017-0315-7","volume":"17","author":"J Wetterslev","year":"2017","unstructured":"Wetterslev J, Jakobsen JC, Gluud C. Trial sequential analysis in systematic reviews with meta-analysis. BMC Med Res Methodol. 2017;17:1\u201318.","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"2716_CR8","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","volume":"61","author":"J Brok","year":"2008","unstructured":"Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol. 2008;61(8):763\u20139.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2716_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","volume":"61","author":"J Wetterslev","year":"2008","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol. 2008;61(1):64\u201375.","journal-title":"J Clin Epidemiol"},{"issue":"9095","key":"2716_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0140-6736(97)08461-4","volume":"351","author":"J Pogue","year":"1998","unstructured":"Pogue J, Yusuf S. Overcoming the limitations of current meta-analysis of randomised controlled trials. Lancet. 1998;351(9095):47\u201352.","journal-title":"Lancet"},{"issue":"6","key":"2716_CR11","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0197-2456(97)00051-2","volume":"18","author":"JM Pogue","year":"1997","unstructured":"Pogue JM, Yusuf S. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. Control Clin Trials. 1997;18(6):580\u201393.","journal-title":"Control Clin Trials"},{"issue":"3","key":"2716_CR12","doi-asserted-by":"publisher","first-page":"659","DOI":"10.2307\/2336502","volume":"70","author":"GK Lan","year":"1983","unstructured":"Lan GK, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70(3):659\u201363.","journal-title":"Biometrika"},{"issue":"7512","key":"2716_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/bmj.38503.623646.8F","volume":"331","author":"P Devereaux","year":"2005","unstructured":"Devereaux P, Beattie WS, Choi PT, Badner NH, Guyatt GH, Villar JC, et al. How strong is the evidence for the use of perioperative \u03b2 blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ. 2005;331(7512):313\u201321.","journal-title":"BMJ"},{"issue":"13\u201314","key":"2716_CR14","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1002\/sim.4780131308","volume":"13","author":"DL DeMets","year":"1994","unstructured":"DeMets DL, Lan KG. Interim analysis: the alpha spending function approach. Stat Med. 1994;13(13\u201314):1341\u201352.","journal-title":"Stat Med"},{"key":"2716_CR15","unstructured":"Thorlund K, Engstr\u00f8m J, Wetterslev J, Brok J, Imberger G, C. G. User manual for trial sequential analysis (TSA) 2011. https:\/\/www.ctudk\/tsa\/files\/tsa_manualpdf"},{"key":"2716_CR16","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ, Higgins JP, Vist GE, Glasziou P, Akl EA, Skoetz N, et al. Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. Cochrane Handb Syst Rev Interv 2019:375\u2013402.","DOI":"10.1002\/9781119536604.ch14"},{"issue":"4","key":"2716_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. introduction\u2014GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64(4):383\u201394.","journal-title":"J Clin Epidemiol"},{"key":"2716_CR18","doi-asserted-by":"publisher","unstructured":"Riberholt CG, Olsen MH, Milan JB, Hafli\u00f0ad\u00f3ttir SH, Svanholm JH, Pedersen EB, et al. Major Mistakes or Errors in the use of Trial Sequential Analysis in Systematic Reviews or Meta-analyses\u2013the METSA Systematic review. Research square. 2023:https:\/\/doi.org\/10.21203\/rs.3.rs-3372546\/v1 [Preprint].","DOI":"10.21203\/rs.3.rs-3372546\/v1"},{"issue":"8952","key":"2716_CR19","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/S0140-6736(95)90646-0","volume":"345","author":"J Villar","year":"1995","unstructured":"Villar J, Carroli G, Beliz\u00e1n JM. Predictive ability of meta-analyses of randomised controlled trials. Lancet. 1995;345(8952):772\u20136.","journal-title":"Lancet"},{"issue":"8","key":"2716_CR20","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1056\/NEJM199708213370806","volume":"337","author":"J LeLorier","year":"1997","unstructured":"LeLorier J, Gr\u00e9goire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med. 1997;337(8):536\u201342.","journal-title":"N Engl J Med"},{"issue":"16","key":"2716_CR21","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jama.1996.03540160054033","volume":"276","author":"JC Cappelleri","year":"1996","unstructured":"Cappelleri JC, Ioannidis JPA, Schmid CH, de Ferranti SD, Aubert M, Chalmers TC, et al. Large trials vs meta-analysis of smaller trials: how do their results compare? JAMA. 1996;276(16):1332\u20138.","journal-title":"JAMA"},{"issue":"2","key":"2716_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/cc8990","volume":"14","author":"SK Aberegg","year":"2010","unstructured":"Aberegg SK, Richards DR, O\u2019Brien JM. Delta inflation: a bias in the design of randomized controlled trials in critical care medicine. Crit Care. 2010;14(2):1\u20137.","journal-title":"Crit Care"},{"issue":"3","key":"2716_CR23","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.bja.2021.06.026","volume":"127","author":"D Sidebotham","year":"2021","unstructured":"Sidebotham D, Popovich I, Lumley T. A bayesian analysis of mortality outcomes in multicentre clinical trials in critical care. Br J Anaesth. 2021;127(3):487\u201394.","journal-title":"Br J Anaesth"},{"issue":"16","key":"2716_CR24","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1001\/jama.2012.13444","volume":"308","author":"TV Pereira","year":"2012","unstructured":"Pereira TV, Horwitz RI, Ioannidis JPA. Empirical evaluation of very large treatment effects of medical interventions. JAMA. 2012;308(16):1676\u201384.","journal-title":"JAMA"},{"issue":"6","key":"2716_CR25","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1213\/ANE.0000000000000892","volume":"121","author":"G Imberger","year":"2015","unstructured":"Imberger G, Gluud C, Boylan J, Wetterslev J. Systematic reviews of anesthesiologic interventions reported as statistically significant: problems with power, precision, and type 1 error protection. Anesth Analg. 2015;121(6):1611\u201322.","journal-title":"Anesth Analg"},{"issue":"12","key":"2716_CR26","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1111\/acem.14312","volume":"28","author":"AJ Parish","year":"2021","unstructured":"Parish AJ, Yuan DMK, Raggi JR, Omotoso OO, West JR, Ioannidis JPA. An umbrella review of effect size, bias, and power across meta-analyses in emergency medicine. Acad Emerg Med. 2021;28(12):1379\u201388.","journal-title":"Acad Emerg Med"},{"issue":"6","key":"2716_CR27","doi-asserted-by":"publisher","first-page":"e072550","DOI":"10.1136\/bmjopen-2023-072550","volume":"13","author":"ML Hansen","year":"2023","unstructured":"Hansen ML, J\u00f8rgensen CK, Thabane L, Rulli E, Biagioli E, Chiaruttini M, et al. Observed intervention effects for mortality in randomised clinical trials: a methodological study protocol. BMJ Open. 2023;13(6):e072550.","journal-title":"BMJ Open"},{"issue":"5","key":"2716_CR28","doi-asserted-by":"publisher","first-page":"e1001645","DOI":"10.1371\/journal.pmed.1001645","volume":"11","author":"J Hislop","year":"2014","unstructured":"Hislop J, Adewuyi TE, Vale LD, Harrild K, Fraser C, Gurung T, et al. Methods for specifying the target difference in a randomised controlled trial: the difference elicitation in trials (DELTA) systematic review. PLoS Med. 2014;11(5):e1001645.","journal-title":"PLoS Med"},{"issue":"1","key":"2716_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-018-2886-y","volume":"19","author":"JC Rothwell","year":"2018","unstructured":"Rothwell JC, Julious SA, Cooper CL. A study of target effect sizes in randomised controlled trials published in the health technology assessment journal. Trials. 2018;19(1):1\u201313.","journal-title":"Trials"},{"issue":"2 Suppl","key":"2716_CR30","doi-asserted-by":"publisher","first-page":"e185S","DOI":"10.1378\/chest.11-2289","volume":"141","author":"GH Guyatt","year":"2012","unstructured":"Guyatt GH, Eikelboom JW, Gould MK, Garcia DA, Crowther M, Murad MH, et al. Approach to outcome measurement in the prevention of thrombosis in surgical and medical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e185S \u2013 e194.","journal-title":"Chest"},{"key":"2716_CR31","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"J Sterne","year":"2019","unstructured":"Sterne J, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ"},{"key":"2716_CR32","doi-asserted-by":"publisher","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343.\u00a0https:\/\/doi.org\/10.1136\/bmj.d5928.","DOI":"10.1136\/bmj.d5928"},{"issue":"1","key":"2716_CR33","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s13643-020-01516-1","volume":"9","author":"SK Korang","year":"2020","unstructured":"Korang SK, Juul S, Nielsen EE, Feinberg J, Siddiqui F, Ong G, et al. Vaccines to prevent COVID-19: a protocol for a living systematic review with network meta-analysis including individual patient data (The LIVING VACCINE Project). Syst Rev. 2020;9(1):262.","journal-title":"Syst Rev"},{"issue":"12","key":"2716_CR34","doi-asserted-by":"publisher","first-page":"e28422","DOI":"10.1371\/journal.pone.0028422","volume":"6","author":"G Imberger","year":"2011","unstructured":"Imberger G, Vejlby AD, Hansen SB, M\u00f8ller AM, Wetterslev J. Statistical multiplicity in systematic reviews of anaesthesia interventions: a quantification and comparison between Cochrane and non-Cochrane reviews. PLoS ONE. 2011;6(12):e28422.","journal-title":"PLoS ONE"},{"issue":"8","key":"2716_CR35","doi-asserted-by":"publisher","first-page":"e011890","DOI":"10.1136\/bmjopen-2016-011890","volume":"6","author":"G Imberger","year":"2016","unstructured":"Imberger G, Thorlund K, Gluud C, Wetterslev J. False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review. BMJ Open. 2016;6(8):e011890.","journal-title":"BMJ Open"},{"issue":"1","key":"2716_CR36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41562-017-0189-z","volume":"2","author":"DJ Benjamin","year":"2018","unstructured":"Benjamin DJ, Berger JO, Johannesson M, Nosek BA, Wagenmakers E-J, Berk R, et al. Redefine statistical significance. Nature Hum Behav. 2018;2(1):6\u201310.","journal-title":"Nature Hum Behav"},{"issue":"9","key":"2716_CR37","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jclinepi.2008.03.004","volume":"61","author":"R Bender","year":"2008","unstructured":"Bender R, Bunce C, Clarke M, Gates S, Lange S, Pace NL, et al. Attention should be given to multiplicity issues in systematic reviews. J Clin Epidemiol. 2008;61(9):857\u201365.","journal-title":"J Clin Epidemiol"},{"key":"2716_CR38","unstructured":"Abdi H. Bonferroni and Sid\u00e1k corrections for multiple comparisons. NJ Salkind (ed) Encyclopedia of Measurement and Statistics Thousand Oaks, CA: Sage. 2007."},{"key":"2716_CR39","unstructured":"Cochrane Hepato-Biliary Group. CHBG Newsletter. Cochrane Hepato-Biliary Group,. 2017;21(1):Available at: https:\/\/hbg.cochrane.org\/chbg-newsletters-0."},{"issue":"1","key":"2716_CR40","first-page":"51","volume":"1","author":"B Zhong","year":"2009","unstructured":"Zhong B. How to calculate sample size in randomized controlled trial? J Thorac Dis. 2009;1(1):51\u20134.","journal-title":"J Thorac Dis"},{"issue":"3","key":"2716_CR41","doi-asserted-by":"publisher","first-page":"e0248132","DOI":"10.1371\/journal.pone.0248132","volume":"16","author":"S Juul","year":"2021","unstructured":"Juul S, Nielsen EE, Feinberg J, Siddiqui F, J\u00f8rgensen CK, Barot E, et al. Interventions for treatment of COVID-19: second edition of a living systematic review with meta-analyses and trial sequential analyses (the LIVING project). PLoS ONE. 2021;16(3):e0248132.","journal-title":"PLoS ONE"},{"key":"2716_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-9-86","volume":"9","author":"J Wetterslev","year":"2009","unstructured":"Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol. 2009;9:1\u201312.","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"2716_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"issue":"12","key":"2716_CR44","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1016\/j.csda.2005.07.019","volume":"50","author":"K Sidik","year":"2006","unstructured":"Sidik K, Jonkman JN. Robust variance estimation for random effects meta-analysis. Comput Stat Data Anal. 2006;50(12):3681\u2013701.","journal-title":"Comput Stat Data Anal"},{"issue":"7","key":"2716_CR45","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/(SICI)1097-0258(19970415)16:7<753::AID-SIM494>3.0.CO;2-G","volume":"16","author":"B Biggerstaff","year":"1997","unstructured":"Biggerstaff B, Tweedie R. Incorporating variability in estimates of heterogeneity in the random effects model in meta-analysis. Stat Med. 1997;16(7):753\u201368.","journal-title":"Stat Med"},{"key":"2716_CR46","unstructured":"Soerensen AL, Olsen MH, Lange T, Gluud C. Package \u2018RTSA\u2019 Available at: chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/cran.r-project.org\/web\/packages\/RTSA\/RTSA.pdf 2023"},{"issue":"17","key":"2716_CR47","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1136\/bjsports-2024-109149","volume":"59","author":"BJ Buckley","year":"2025","unstructured":"Buckley BJ, Long L, Lane DA, Risom S, Fitzhugh CJ, Berg SK, Taylor RS. Exercise based cardiac rehabilitation for atrial fibrillation: Cochrane systematic review, meta-analysis, meta-regression and trial sequential analysis. British J Sports Med. 2025;59(17):1242\u201353.","journal-title":"British J Sports Med"},{"key":"2716_CR48","unstructured":"Copenhagen Trial Unit. TSA - Trial Sequential Analysis [Web page]. [Available from: http:\/\/www.ctu.dk\/tsa\/."},{"issue":"1","key":"2716_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/ije\/dyn188","volume":"38","author":"J Brok","year":"2008","unstructured":"Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive\u2014trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int J Epidemiol. 2008;38(1):287\u201398.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"2716_CR50","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/ije\/dyn179","volume":"38","author":"K Thorlund","year":"2008","unstructured":"Thorlund K, Devereaux P, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al. Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? Int J Epidemiol. 2008;38(1):276\u201386.","journal-title":"Int J Epidemiol"},{"key":"2716_CR51","unstructured":"Thorlund K, Engstr\u00f8m J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for trial sequential analysis (TSA). Copenhagen, Denmark: Copenhagen Trial Unit, Centre for Clinical Intervention Research; 2011. Available from: http:\/\/www.ctu.dk\/tsa\/files\/tsa_manual.pdf."},{"key":"2716_CR52","doi-asserted-by":"crossref","unstructured":"Thorlund K, Anema A, Mills E. Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals. J Clin Epidemiol. 2010;2:57\u201366.","DOI":"10.2147\/CLEP.S9242"},{"key":"2716_CR53","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jclinepi.2022.07.015","volume":"150","author":"HJ Sch\u00fcnemann","year":"2022","unstructured":"Sch\u00fcnemann HJ, Neumann I, Hultcrantz M, Brignardello-Petersen R, Zeng L, Murad MH, et al. Grade guidance 35: update on rating imprecision for assessing contextualized certainty of evidence and making decisions. J Clin Epidemiol. 2022;150:225\u201342.","journal-title":"J Clin Epidemiol"},{"key":"2716_CR54","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jclinepi.2022.07.014","volume":"150","author":"L Zeng","year":"2022","unstructured":"Zeng L, Brignardello-Petersen R, Hultcrantz M, Mustafa RA, Murad MH, Iorio A, et al. Grade guidance 34: update on rating imprecision using a minimally contextualized approach. J Clin Epidemiol. 2022;150:216\u201324.","journal-title":"J Clin Epidemiol"},{"key":"2716_CR55","doi-asserted-by":"publisher","unstructured":"Kuehn R, Wang Y, Guyatt G. Overly complex methods may impair pragmatic use of core evidence-based medicine principles. BMJ Evid Based Med. 2024:Epub ahead of print.\u00a0https:\/\/doi.org\/10.1136\/bmjebm-2024-112868.","DOI":"10.1136\/bmjebm-2024-112868"},{"key":"2716_CR56","doi-asserted-by":"publisher","unstructured":"Storeb\u00f8 OJ, Storm MR, Pereira Ribeiro J, Skoog M, Groth C, Callesen HE, et al. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). Cochrane Database of Syst Rev. 2023(3). https:\/\/doi.org\/10.1002\/14651858.CD009885.pub3.","DOI":"10.1002\/14651858.CD009885.pub3"},{"key":"2716_CR57","doi-asserted-by":"publisher","unstructured":"Bjelakovic M, Nikolova D, Bjelakovic G, Gluud C. Vitamin D supplementation for chronic liver diseases in adults. Cochrane Database of Syst Rev. 2021(8).\u00a0https:\/\/doi.org\/10.1002\/14651858.CD011564.pub3.","DOI":"10.1002\/14651858.CD011564.pub3"},{"key":"2716_CR58","doi-asserted-by":"crossref","unstructured":"Kumburegama WMBB, Kristensen AT, Bjelakovic G, Nikolova D, Asante M, Bjelakovic M, et al. Direct-acting antivirals for chronic hepatitis C infection: a protocol for a systematic review of observational studies. PROSPERO - International prospective register of systematic reviews. 2023:Registration. Available at: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42023494844. Accessed 8 May 2024.","DOI":"10.1101\/2024.10.21.24315594"}],"container-title":["BMC Medical Research Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-025-02716-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12874-025-02716-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12874-025-02716-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T15:03:16Z","timestamp":1764946996000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedresmethodol.biomedcentral.com\/articles\/10.1186\/s12874-025-02716-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2716"],"URL":"https:\/\/doi.org\/10.1186\/s12874-025-02716-w","relation":{},"ISSN":["1471-2288"],"issn-type":[{"value":"1471-2288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}